Madison Wealth Partners Inc Acquires Shares of 5,291 Danaher Corporation $DHR

Madison Wealth Partners Inc bought a new position in Danaher Corporation (NYSE:DHRFree Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 5,291 shares of the conglomerate’s stock, valued at approximately $1,008,000.

Other institutional investors also recently bought and sold shares of the company. High Note Wealth LLC lifted its stake in Danaher by 19.2% in the 4th quarter. High Note Wealth LLC now owns 292 shares of the conglomerate’s stock worth $67,000 after purchasing an additional 47 shares in the last quarter. First Command Advisory Services Inc. grew its position in shares of Danaher by 4.4% during the fourth quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate’s stock valued at $253,000 after purchasing an additional 47 shares in the last quarter. GW&K Investment Management LLC increased its holdings in shares of Danaher by 8.4% in the fourth quarter. GW&K Investment Management LLC now owns 605 shares of the conglomerate’s stock worth $138,000 after purchasing an additional 47 shares during the last quarter. Kestra Private Wealth Services LLC lifted its position in shares of Danaher by 0.3% in the third quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate’s stock worth $3,057,000 after buying an additional 48 shares in the last quarter. Finally, SOL Capital Management CO lifted its position in shares of Danaher by 2.7% in the fourth quarter. SOL Capital Management CO now owns 1,879 shares of the conglomerate’s stock worth $430,000 after buying an additional 50 shares in the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Price Performance

Shares of Danaher stock opened at $219.42 on Friday. The stock has a market cap of $154.25 billion, a price-to-earnings ratio of 38.97, a price-to-earnings-growth ratio of 2.72 and a beta of 0.78. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The stock has a 50 day moving average price of $195.80 and a 200-day moving average price of $192.61. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80.

Danaher (NYSE:DHRGet Free Report) last released its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating the consensus estimate of $1.85 by $0.09. The company had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.Danaher’s quarterly revenue was up 5.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.77 EPS. Equities analysts expect that Danaher Corporation will post 8.53 EPS for the current year.

Wall Street Analyst Weigh In

DHR has been the topic of several recent research reports. Wells Fargo & Company decreased their price objective on Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a report on Wednesday, July 22nd. Royal Bank Of Canada boosted their price target on shares of Danaher from $200.00 to $215.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 22nd. Wall Street Zen downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, April 25th. Evercore reiterated an “outperform” rating and set a $230.00 price objective on shares of Danaher in a research report on Monday, July 6th. Finally, Guggenheim dropped their price objective on shares of Danaher from $235.00 to $200.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have issued a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $228.91.

Check Out Our Latest Report on DHR

About Danaher

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Recommended Stories

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.